Literature DB >> 22332937

Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.

T Baglin1, K Bauer, J Douketis, H Buller, A Srivastava, G Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22332937     DOI： 10.1111/j.1538-7836.2012.04662.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  22 in total

1.  Unusual venous thrombosis in a 35-year-old man.

Authors:  Ami Schattner
Journal:  CMAJ       Date:  2013-10-28       Impact factor: 8.262

2.  Deep vein thrombosis in a transgender woman.

Authors:  Wesley Chan; Alasdair Drummond; Martina Kelly
Journal:  CMAJ       Date:  2017-04-03       Impact factor: 8.262

Review 3.  The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal.

Authors:  James Demetrios Douketis
Journal:  Intern Emerg Med       Date:  2016-10-20       Impact factor: 3.397

4.  [Choosing wisely recommendations in angiology].

Authors:  O J Müller; R Sternitzky
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

Review 5.  Abnormal Uterine Bleeding in Young Women with Blood Disorders.

Authors:  Kathryn E Dickerson; Neethu M Menon; Ayesha Zia
Journal:  Pediatr Clin North Am       Date:  2018-06       Impact factor: 3.278

6.  Testing for thrombophilia: clinical update.

Authors:  Neil Graham; Hunaid Rashiq; Beverley J Hunt
Journal:  Br J Gen Pract       Date:  2014-02       Impact factor: 5.386

Review 7.  Estrogen and thrombosis: A bench to bedside review.

Authors:  Mouhamed Yazan Abou-Ismail; Divyaswathi Citla Sridhar; Lalitha Nayak
Journal:  Thromb Res       Date:  2020-05-11       Impact factor: 3.944

8.  Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.

Authors:  Ida Martinelli; Anthonie W A Lensing; Saskia Middeldorp; Marcel Levi; Jan Beyer-Westendorf; Bonno van Bellen; Henri Bounameaux; Timothy A Brighton; Alexander T Cohen; Mila Trajanovic; Martin Gebel; Phuong Lam; Philip S Wells; Martin H Prins
Journal:  Blood       Date:  2015-12-22       Impact factor: 22.113

Review 9.  Duration of anticoagulation for venous thromboembolic events.

Authors:  Nathaniel R Smilowitz; Jessica L Mega; Jeffrey S Berger
Journal:  Circulation       Date:  2014-12-23       Impact factor: 29.690

Review 10.  Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?

Authors:  Fionnuala Ní Áinle; Barry Kevane
Journal:  Blood Adv       Date:  2020-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.